Pharmacovigilance and Risk Management

Pharmacovigilance and Risk Management comprises set of pharmacovigilance activities and interventions designed to identify, characterise, prevent or minimise risks relating to medicinal and therapeutic products including the assessment of the effectiveness of their clinical interventions and combination therapies. Drug industry need to promote companies in pharmacovigilance practice to use information technology and to review softwares used in pharmacovigilance and clinical trials. Monitoring unlicensed, off labels and orphan drugs is major task in risk management. Many experts from different pharmacovigilance CRO’s pharmacovigilance service providers and industrial delegates are participating in this conference to share their knowledge and discuss about the new updates.

Market Analysis: The global Pharmacovigilance Market is expected to reach USD 10.27 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness growth at 13.1% CAGR owing to Increasing incidence of ADR is key driver for the growth of pharmacovigilance market. As of 2015, the U.S. FDA received approximately 253,017 serious adverse events and 44,693 deaths associated with adverse drug reactions (ADRs). This shows the potential demand for implementing safety and pharmacovigilance services over the forecast period

Related industrys: TCS, Novartis, Paraxel, Quintiles, Cognizant, Jubilant, Biosys, APCER, Sun Pharma, Lambda, INC Research, Alembic, SunPharma

Societies and Associations

International Society of PharmacovigilanceEuropean Society for Clinical InvestigationInternational Society of PharmacovigilanceClinical Research SocietyJapan CRO AssociationAssociation of Clinical Research ProfessionalsAmerican Association of Pharmaceutical ScientistsPan-Asian Clinical Research AssociationThe Society of Clinical Research Associates

  • Information technology in pharmacovigilance and promoting companies
  • Review of softwares used in pharmacovigilance and clinical trials
  • Implementation of Risk Minimization Plans
  • Risk communication: Interface between pharmacovigilance, sales and marketing

Related Conference of Pharmacovigilance and Risk Management

August 26-27, 2020

33rd World Congress on Pharmacology

Barcelona, Spain
August 26-26, 2020

pharmaceutics and drug discovery

London, UK
August 31-01, 2020

13th European Biosimilars Congress 2020

London, UK
September 07-08, 2020

Global Summit on Generic Drugs and Quality Control

Prague, Czech Republic
September 09-10, 2020

World Pharma Expo

Amsterdam, Netherlands
September 10-11, 2020

World Congress on Rare Diseases & Orphan Drugs

Prague, Czech Republic
September 14-15, 2020

16th Annual Congress on Pharmacology and Toxicology

Vienna, Austria
September 16-17, 2020

Global Pharmacovigilance And Clinical Trials Summit

Shanghai, China
September 18-19, 2020

International Conference on Pharmaceutical Chemistry

Dubai, UAE
September 21-22, 2020

35th World Pharmacology and Toxicology Forum

Tokyo, Japan
September 22-23, 2020

6th Annual Congress on Clinical & Hospital Pharmacy

Singapore City, Singapore
September 24-25, 2020

20th World Congress on Advances in Pharmaceutical Sciences

Singapore, Singapore
October 05-06, 2020

International Congress on Drug Delivery

Auckland, Newzealand
October 15-16, 2020

nanomedicine-pharma-2020

Rome, Italy
October 21-22, 2020

20th Annual Meet on Pharmaceutical Sciences

Bangkok, Thailand
October 21-22, 2020

27th World Congress on Pharmacovigilance and Clinical Trials

Frankfurt, Germany
October 26-27, 2020

22nd International Conference on Drug Design and Development

Amsterdam, Netherlands
November 09-10, 2020

2nd World Congress on Drug Discovery and Drug Design

Tokyo, Japan
November 09-10, 2020

21st Global Summit on Analytical and Bioanlaytical Techniques

Amsterdam, Netherlands
November 9-10, 2020

Annual Meet on Pharmacovigilance & Drug Safety

Tokyo, Japan
November 09-10, 2020

20th Medicinal & Pharmaceutical Sciences Congress

Budapest, Hungary
November 09-10 , 2020

Asia Pacific Pharmaceutics & Drug Delivery Congress

| Tokyo , Japan
November 11-12, 2020

4th World Congress on Eye and Vision

Dubai, UAE
November 16-17, 2020

World Congress on Biologics and Biosimilars

Kyoto, Japan
November 19-20, 2020

Global summit on Cosmetic and Reconstructive Surgery

Tokyo, Japan
November 23-24, 2020

Pharma Expo China

Paris, France
November 23-24, 2020

Pharmaceutics & Novel Drug Delivery Summit China

Paris, France
November 23-24, 2020

21st Middle East PharmaTech & Expo

Istanbul, Turkey
November 25-26, 2020

8th World Congress on Antibiotics, Antimicrobials & Antibiotic Resistance

Singapore City, Singapore
November 26-27, 2020

11th World Congress on Bioavailability and Bioequivalence

Istanbul, Turkey
December 02-03, 2020

2nd International Conference on Bio-Pharmaceuticals

Auckland, Newzealand
December 07-08, 2020

International Liver Congress

Dubai, UAE
December 07-08, 2020

International Conference on Biotechnology and Healthcare

Auckland, Newzealand
May 11-12, 2021

6th Pharmaceutical Chemistry Conference

Paris, France
May 18-19, 2021

8th European Biopharma Congress

Prague, Czech Republic

Pharmacovigilance and Risk Management Conference Speakers

Recommended Sessions

Related Journals

Are you interested in